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When Cites sanctioned the last 
ivory sale in 2007, it was agreed that 
there would be no more such one-off 
sales for at least nine years, and 
Tanzania and Zambia are seen as 
having reneged on this. Their move 
has aroused resentment among 
other African states, which are now 
trying to protect their threatened 
and dwindling elephant populations 
with a motion for next month’s 
meeting calling for a 20- year ban on 
any such sales, from the date of the 
last one.
And delegates from the 
23- government African Elephant 
Coalition have been in Brussels 
trying to persuade the EU 
Commission, the European 
Parliament and EU member states 
to oppose the new sale. “This really 
is the last call for the elephants 
in Africa,” said Bourama Niagate, 
director of parks and natural 
reserves in Mali. “The devastating 
poaching of the 1980s first 
controlled through Cites is now so 
prevalent that the African elephant 
is all but extinct in some countries. 
This is because limited legal sales 
of ivory were allowed in the recent 
past providing the perfect cover 
for illegal trade in poached ivory,” 
he says.
Elephants once ranged widely 
across the whole of sub-Saharan 
Africa but are now found only in 
substantial numbers in the few 
southern countries with policies in 
place to protect them. In Botswana, 
elephant numbers have increased 
with conservation measures over 
the past 40 years to an estimated 
130,000 animals. Zimbabwe says that 
it is now home to more than 100,000 
elephants, but critics says this figure 
may be almost double the true 
numbers. And, of course, elephants 
cross national boundaries so are 
more difficult to census. Numbers 
of southern African elephants 
contrast sharply with those further 
north, where populations are facing 
extinction.
“If we do not let elephant 
populations recover over the next 
20 years by stopping the trade 
entirely, there will be no more African 
elephants outside a few zoological 
specimens in reserves in southern 
parts of Africa. Europe needs to do 
the right thing and back our stance 
now because it is nearly too late,” 
says Niagate.
extraordinary amount, and again 
achieved the distinction of being a B-
student without Bs. Ed Southin taught 
a magnificent course entirely based 
on the literature of the still infant field 
of molecular biology. My interests in 
physics went by the wayside — I was 
entirely hooked by the elegance of 
this science. I got into the laboratory 
of Barad Mukherjee, the first of many 
mentors who were to let me play at 
science unfettered by any disciplined 
plan. I was 18 and infatuated with 
science. I loved every part of it — the 
ideas, the insights in the literature, 
the experiments, the inventive part 
of getting methods to work, the 
excitement of doing new things and 
the thrill of seeing the outcome. After 
42 years, science is still new and 
vibrant, and I am still in love. 
You developed two-dimensional 
gel electrophoresis as a graduate 
student: what motivated this 
work? Though the circumstances 
were complicated and the goal 
outrageously ambitious, the reasons 
were simple. As a student in Boulder 
Colorado, I lost my first advisor, 
Joe Daniel, when he left to take 
a chairmanship. Jacques Pène, a 
young faculty member working on 
bacteriophage gene expression, 
talked to me of his interest in starting 
to work with Volvox, a colonial green 
alga, as a model for developmental 
biology. It is a beautiful organism 
with a remarkably simple embryonic 
development and two-day life cycle. 
I was fascinated by the possibilities 
and I joined his lab to begin this 
project. I quickly discovered that it 
was easy to isolate mutations with 
altered morphology. I wanted to 
dissect the connections between 
gene and morphology. At the time 
(1971), there was one success along 
these lines. The newly introduced 
Laemmli SDS gels resolved most 
of the proteins produced by 
bacteriophage, allowing investigators 
to dissect the progression of gene 
expression during phage infection 
and assess the affects of mutations. 
Because I could synchronize Volvox 
development and could isolate 
mutants, I thought that I could use 
the same experimental paradigm; 
however, I needed a gel system that 
could resolve the much larger number 
of proteins made by a eukaryote. I set 
my goal at squaring the resolution of 
SDS gels by combining two methods 
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How did you get into biology? 
I seem to have been born into 
it. Not in that I was born into a 
scientific environment. My father 
was in the Canadian military, and 
I grew up going to parochial schools 
and moving every few years. But 
I was born into it in the sense that 
I was very good at some things 
and terrible at others, especially 
spelling. I went through school an 
average ‘B-student’, exceptional 
only in that I accomplished this 
without any Bs. The sciences were 
easy and attractive, but there was 
no illuminated path to a career in 
science. School taught us about 
‘gentlemen’ and monks whose 
individual efforts established the 
foundations of modern science, but 
I assumed I needed to find a real 
career to support a hobby of doing 
experiments. Now, when I anguish 
over the difficulty of funding our work, 
I remember this youthful view and 
marvel that I get paid for what I do. 
Miraculously, when we moved to 
Montreal, McGill admitted me, the 
peculiar B-student. I gained access 
to a wealth of intense science 
courses well above my head. I took 
far too many courses, learned an 
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in a two-dimensional separation — 
this eventually gave me the ability to 
detect about 2,000 gene products. 
Once you had decided, was it just 
a matter of doing it? Hardly! There 
were a million things that needed 
to be worked out and a million 
things that could go wrong — and 
most did. I had a curious blend 
of stubbornness, confidence and 
optimism that led me to believe that 
I knew exactly what was needed to 
improve the separation no matter the 
failures and the ugly looking results 
along the way. It was a consuming 
process. 
What happened to Volvox? Perhaps 
you could say that it gave me the 
first of many lessons in scientific 
humility. Establishing a new genetic 
model has many components and 
all that I had was lots of mutants 
with cute phenotypes. It seemed 
that the testing grounds for the new 
method ought to be in a system with 
people and tools that might help 
me. I chose Escherichia coli, where 
I could address questions that had 
been well delineated by others. For 
example, I was able to show that all 
detectable effects of cyclic AMP are 
mediated by the one known receptor. 
The questions and approaches were 
those of ‘proteomics’, although the 
work presaged the name and the 
era when the scientific community 
developed a taste for large-scale 
analysis. 
How did you come to be the sole 
author of the two-dimensional 
gel paper as a graduate student? 
At the time it seemed natural and 
appropriate. I lost my second advisor 
when Jacques Pène left for a position 
in New Jersey. So, in the midst of 
developing the method, I moved to 
the laboratory of David Hirsh, a young 
Assistant Professor studying the 
nematode Caenorhabditis elegans. 
When I wrote the paper, it didn’t 
really occur to me that I should 
include any other author. While the 
sole authorship still seems to be a 
fair reflection of my autonomy, I feel 
bad that it does not acknowledge 
the debt that I owe my advisors for 
their support, for the confidence they 
placed in me, and for their willingness 
to just let me go. Additionally, there 
was a terrific interactive environment 
in the Department in Boulder, and I 
owe a great deal to Larry Gold and 
members of his laboratory, among 
others, for technical help and for 
enthusiastic promotion of the work 
when the method proved so powerful. 
How was the work received? On 
the one hand there was a voracious 
appetite for a method that would 
allow people to follow specific gene 
products in complex mixtures. 
On the other hand, the Journal of 
Biological Chemistry initially rejected 
the paper on the basis of two very 
brief negative reviews that suggested 
that the manuscript was “highly 
speculative in places and to be 
extrapolated in terms of usefulness 
far beyond what the author has any 
reason to expect”. Prompted by 
appeals from two editors familiar with 
the work, Bill Rutter and Bruce Ames, 
the Journal of Biological Chemistry 
re-reviewed the manuscript and 
ultimately accepted it. For many 
years, the paper has been among 
the most cited papers in biology (for 
example, it was listed among the 50 
most highly cited papers in 2004). 
When you started your own 
laboratory in 1979, you began 
working on Drosophila: what 
stimulated this change? I wanted to 
understand the molecular code that 
biology used to shape an embryo and 
I wasn’t getting there by analysing 
changes in protein expression. 
Stimulated by the environment at 
UCSF and smart friends, I started 
looking at fly genetics for ways to 
approach development. Ed Lewis’s 
papers convinced me that identifying 
homeotic genes would provide the 
needed clues, and I thought the new 
recombinant DNA biology would 
provide the requisite tools.  We set 
out to clone homeotic genes thinking 
of it as a lonely adventure, only to 
discover that we were participants in 
an exploding field. 
You subsequently contributed to 
very different research areas: why 
did you switch areas and is it a 
strategy you recommend? Science 
changes remarkably over the period 
of a scientific career, but scientists 
tend not to change — many retire 
working on a topic inherited from 
an advisor during their training. 
Science is supposed to be about 
innovation, but increasingly, fear for 
career security seems to channel 
scientists into ruts. So, yes! Not only 
do I advise people to change, I train 
them to look for new questions and 
encourage them to find the boldness 
to pursue the adventure that science 
should be. 
But aren’t there difficulties in 
starting something new? Yes 
and the difficulties are of two sorts. 
First, it is difficult in much the way 
a vigorous physical work-out is 
difficult. It takes an abundance 
of scholarly effort to develop a 
foundation of knowledge in a new 
area. It also takes deep thought to 
identify novel directions — after 
all it would be pointless to simply 
switch to things that others are 
already pursuing. Like exercise, these 
efforts come with rewards. Learning 
new things is refreshing and a new 
area turns one’s thinking from little 
intricacies to the big picture. 
The second type of difficulty, 
unfortunately, is burdensome, and 
sadly it is imposed by one’s peers. 
We don’t allow each other to change. 
Instead of instilling confidence in our 
abilities, our scientific reputations 
are the chains that bind us to the 
research question that we are 
identified with. 
Did you encounter a downside to 
changes in your research focus? 
Personally, identifying new problems 
has been rewarding, and rejuvenating, 
but there are costs and limitations. 
Not every effort to start something 
new takes off, and stumbling can take 
more energy than identifying a clear 
path. Additionally, doing something 
important and making an impact 
takes time, so starting in a new area 
is not an annual affair. I have usually 
invested at least ten years into 
the pursuit of a particular area. On 
balance, I think changes in research 
focus have added importantly to what 
we’ve been able to accomplish, and 
has enriched the research careers 
of the people I’ve trained. Really, my 
only regret is that with each change 
of research area, there has been a 
change in scientific colleagues, and I 
find that I am not able to change my 
affiliations and affections as readily  
as my science.
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